Revolutionary ‘Fat Destructing’ Injection Promises to Change the Game for Mounjaro and Ozempic Users—Is This the Ultimate Weight Loss Breakthrough?
So, here’s a nugget for you: what if the battle against stubborn fat wasn’t about shrinking those pesky cells but straight-up assassinating them? Sounds dramatic, right? Well, buckle up, because the University of Alabama at Birmingham is tossing the old playbook out the window with their experimental drug, CBL-514. Unlike Mounjaro or Ozempic—which have been the go-to weight warriors—this new treatment promises a full-on cellular cleanup, targeting not just the “pinchable” fat under your skin, but also that sneaky visceral fat cozying up around your organs. The stakes? Major health perks, from lowering heart disease risk to battling diabetes. Early buzz from phase 2 trials is buzzing with decent promise, even if peer reviews haven’t swooped in yet. If this pans out, weight loss might just get a whole new face—and maybe finally deliver on that flatter stomach dream without the usual dance. Ready to see if CBL-514 can dethrone the reigning champs?
A new treatment could mean major changes are on the horizon for those who currently rely on Mounjaro or Ozempic to help them manage their weight.
That’s because the University of Alabama at Birmingham in the US is currently running clinical trials for a brand-new fat reduction treatment that uses a different method to target fat.
Researchers reported the findings at the annual meeting of the European Association for the Study of Diabetes in Milan, Italy on 1 October.
Instead of shrinking fat cells like many of the on-the-market injections do, the injectable CBL-514 reduces both subcutaneous and visceral fat by killing off the cells entirely.
Known as the ‘fat you can pinch’, subcutaneous fat, per the Cleveland Clinic, it is ‘found just under your skin’ and when a person has too much of it, it can lead ‘to serious health issues including heart disease, diabetes, stroke and more.’
Apparently, CBL-514 targets two types of fat (Getty Stock Images)
However, visceral fat is that which is around your organs and is harder to remove and much more dangerous for your health.
According to the team, the phase 2 clinical trials showed that the drug was effective in removing both when used by the majority of participants.
While the drug hasn’t been peer reviewed, the results seem promising.
The two phase 2 trials, named CBL-0204 and CBL-0205, saw107 and 173 participants take CBL-514.
In both, it was found to reduce subcutaneous fat in the majority of the groups.
As for those who were given the drug for up to 12 weeks, they were discovered to have seen average reduction of 12.01 percent in visceral fat, compared to the 5.68 percent increase in fat seen in those who took a placebo four weeks after their final injection.
“We expect that patients will be pleased by the cosmetic effects, such as the flatter stomach that can come with subcutaneous fat loss,” said endocrinologist Timothy Garvey, from the University of Alabama at Birmingham.
“But it is the reduction in body weight, loss of visceral fat and the improvements in blood pressure, cholesterol and the like that should be associated with this that will be important for health.”
Researchers say study participants found success with losing weight (Getty Stock Images)
CBL-514 was originally developed to remove fatty lumps under the skin called lipomas. However, the research suggests that the drug has been effective at both decreasing weight and making it harder to gain once the treatment has stopped.
“This is a highly innovative approach to obesity pharmacotherapy that has produced some remarkable results in early human trials,” added Garvey.
For now, the team hopes they will be able to conduct an even bigger trial to see the impact on a larger scale.
If it proves to be successful, CBL-514 could be the latest weight-loss drug on the market which rivals the current frontrunners from Novo Nordisk (Ozempic and Wegovy) and Eli Lilly (Mounjaro).
Ozempic is a type 2 diabetes management treatment that is a GLP-1 medication.
However, many people, including high-profile celebrities, have been finding success with the jabs to lose weight thanks to its ability to also target the brain’s appetite receptor.
LADbible reached out to Novo Nordisk and Eli Lilly for comment.
KiddyCare Diaper Caddy Organizer Cart for Nursery Baby Basket Gift for Boy/Girl | Diaper Caddy for Changing Table Basket Organizer with Dividers | Caddy for Baby Stuff Breast Pump Caddy - Regular
$9.99 (as of October 19, 2026 01:01 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
Joking Hazard by Cyanide & Happiness - 360+ Funny & Inappropriate Comic Cards, Hilarious Party Games | Includes Add-Your-Own-Words Cards
$24.95 (as of October 19, 2026 01:01 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
RIVER OF GOODS Stained Glass Magna Carta LED Ceiling Fan - 52" L x 52" W - Tiffany Style - Flush Mount Ceiling Fan with Remote - Teal
(as of October 19, 2026 01:01 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
The Door Balancer Eliminates The Need for Door Props, Door Stops and Door Wedges
(as of October 19, 2026 01:01 GMT +00:00 - More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)
Post Comment